Ganga Pharmaceuticals Balans Gezondheid
Financiële gezondheid criteriumcontroles 5/6
Ganga Pharmaceuticals has a total shareholder equity of ₹70.5M and total debt of ₹13.6M, which brings its debt-to-equity ratio to 19.3%. Its total assets and total liabilities are ₹86.5M and ₹16.0M respectively. Ganga Pharmaceuticals's EBIT is ₹84.2K making its interest coverage ratio -0.1. It has cash and short-term investments of ₹298.3K.
Belangrijke informatie
19.3%
Verhouding schuld/eigen vermogen
₹13.58m
Schuld
| Rente dekkingsratio | -0.1x |
| Contant | ₹298.30k |
| Aandelen | ₹70.53m |
| Totaal verplichtingen | ₹15.95m |
| Totaal activa | ₹86.48m |
Recente financiële gezondheidsupdates
Geen updates
Recent updates
Analyse van de financiële positie
Kortlopende schulden: 539680's short term assets (₹57.5M) exceed its short term liabilities (₹12.0M).
Langlopende schulden: 539680's short term assets (₹57.5M) exceed its long term liabilities (₹4.0M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: 539680's net debt to equity ratio (18.8%) is considered satisfactory.
Schuld verminderen: 539680's debt to equity ratio has reduced from 36.3% to 19.3% over the past 5 years.
Schuldendekking: 539680's operating cash flow is negative, therefore debt is not well covered.
Rentedekking: 539680 earns more interest than it pays, so coverage of interest payments is not a concern.